The G-protein-coupled CCK2 receptor associates with phospholipase Cγl

被引:13
作者
Arnould, M
Tassa, A
Ferrand, A
Archer, E
Estève, JP
Pénalba, V
Portolan, G
Escherich, A
Moroder, L
Fourmy, D
Seva, C
Dufresne, M
机构
[1] CHU Rangueil, IFR31, INSERM, U531,Inst Louis Bugnard, Toulouse, France
[2] CHU Rangueil, IFR31, Funct Proteom Facil, Toulouse, France
[3] CHU Rangueil, IFR31, Toulouse, France
[4] Max Planck Inst Biochem, Martinsried, Germany
关键词
G-protein-coupled receptor; phospholipase C; CCK2; receptor; precancerous condition; surface plasmon resonance; gastrin;
D O I
10.1016/j.febslet.2004.05.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In ElasCCK2 transgenic mice expressing cholecystokinin (CCK2) receptor in acinar cells, pancreatic phenotypic alterations and preneoplastic lesions are observed. We determined whether activation of phospholipase C gammal (PLCgamma1), known to contribute to the tumorigenesis pathophysiology, could take place as a new signaling pathway induced by the CCK2 receptor. Overexpression and activation of the PLCgamma1 in response to gastrin was observed in acinar cells. The possibility that the C-terminal tyrosine 438 of the CCK2 receptor associates with the SH2 domains of PLCgamma1 was examined. A specific interaction was demonstrated using surface plasmon resonance, confirmed in a cellular system and by molecular modeling. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:89 / 93
页数:5
相关论文
共 26 条
[1]   Gastrin mediated cholecystokinin-2 receptor activation induces loss of cell adhesion and scattering in epithelial MDCK cells [J].
Bierkamp, C ;
Kowalski-Chauvel, A ;
Dehez, S ;
Fourmy, D ;
Pradayrol, L ;
Seva, C .
ONCOGENE, 2002, 21 (50) :7656-7670
[2]   The 'magic tail' of G protein-coupled receptors: an anchorage for functional protein networks [J].
Bockaert, J ;
Marin, P ;
Dumuis, A ;
Fagni, L .
FEBS LETTERS, 2003, 546 (01) :65-72
[3]   Expression of CCK2 receptors in the murine pancreas: Proliferation, transdifferentiation of acinar cells, and neoplasia [J].
Clerc, P ;
Leung-Theung-Long, S ;
Wang, TC ;
Dockray, GJ ;
Bouisson, M ;
Delisle, MB ;
Vaysse, N ;
Pradayrol, L ;
Fourmy, D ;
Dufresne, M .
GASTROENTEROLOGY, 2002, 122 (02) :428-437
[4]   Overexpression of kidney phosphatidylinositol 4-kinaseβ and phospholipase Cγ1 proteins in two rodent models of polycystic kidney disease [J].
Cuozzo, FP ;
Mishra, S ;
Jiang, J ;
Aukema, HM .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (01) :99-106
[5]   Src-family tyrosine kinases in activation of ERK-1 and p85/p110-phosphatidylinositol 3-kinase by G/CCKB receptors [J].
Daulhac, L ;
Kowalski-Chauvel, A ;
Pradayrol, L ;
Vaysse, N ;
Seva, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (29) :20657-20663
[6]  
Dehez S, 2002, CELL GROWTH DIFFER, V13, P375
[7]   The biologically crucial C terminus of cholecystokinin and the non-peptide agonist SR-146,131 share a common binding site in the human CCK1 receptor - Evidence for a crucial role of Met-121 in the activation process [J].
Escrieut, C ;
Gigoux, V ;
Archer, E ;
Verrier, S ;
Maigret, B ;
Behrendt, R ;
Moroder, L ;
Bignon, E ;
Silvente-Poirot, S ;
Pradayrol, L ;
Fourmy, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (09) :7546-7555
[8]   Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation [J].
Ferjoux, G ;
Lopez, F ;
Esteve, JP ;
Ferrand, A ;
Vivier, E ;
Vely, F ;
Saint-Laurent, N ;
Pradayrol, L ;
Buscail, L ;
Susini, C .
MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (09) :3911-3928
[9]   A NEW PROBE FOR AFFINITY LABELING PANCREATIC CHOLECYSTOKININ RECEPTOR WITH MINOR MODIFICATION OF ITS STRUCTURE [J].
FOURMY, D ;
LOPEZ, P ;
POIROT, S ;
JIMENEZ, J ;
DUFRESNE, M ;
MORODER, L ;
POWERS, SP ;
VAYSSE, N .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1989, 185 (02) :397-403
[10]  
Ghrib F, 1998, INT J CANCER, V75, P239, DOI 10.1002/(SICI)1097-0215(19980119)75:2<239::AID-IJC12>3.0.CO